Sleep in Collegiate Baseball Players
Assessing and Optimizing Sleep, Diet, and Performance in Columbia University Baseball Players
1 other identifier
interventional
38
1 country
1
Brief Summary
Sleep is an essential biological function that impacts nearly every aspect of an athlete's physical and mental health. For athletes, the importance of high-quality sleep cannot be overstated, as it plays a critical role in performance, recovery, and overall well-being. Sleep supports muscle recovery by promoting protein synthesis and the release of growth hormones, essential for healing after intense physical exertion. Furthermore, adequate sleep is crucial for maintaining cognitive sharpness, decision-making abilities, and emotional regulation-all of which are necessary for optimal athletic performance. The study will assess both sleep quality and quantity in baseball players at Columbia University. These tools will help quantify key sleep metrics, including sleep duration, latency (the time it takes to fall asleep), and the number of awakenings during the night. Similarly, the study will analyze dietary patterns using the Automated Self-Administered 24-Hour Dietary Assessment (ASA24), tracking nutrient intake, meal timing, and the consumption of ultra-processed foods. These assessments will establish a baseline from which to measure improvement post-intervention. The intervention will focus on improving diet, time in bed, and light exposure to improve sleep, diet, and performance in collegiate baseball athletes.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started Sep 2025
Shorter than P25 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
September 16, 2025
CompletedFirst Submitted
Initial submission to the registry
September 23, 2025
CompletedFirst Posted
Study publicly available on registry
October 8, 2025
CompletedPrimary Completion
Last participant's last visit for primary outcome
October 31, 2025
CompletedStudy Completion
Last participant's last visit for all outcomes
October 31, 2025
CompletedDecember 18, 2025
December 1, 2025
2 months
September 23, 2025
December 11, 2025
Conditions
Outcome Measures
Primary Outcomes (4)
Athletic performance (position-specific for batters and pitchers)
Batters: Baseball radar gun, outcome is exit velocity (speed at which ball leaves the bat, in miles/h) Pitchers: Baseball radar gun measuring velocity (miles/h)
pre and post intervention (4-6 weeks)
Sleep quality
Duration (h:min)
Nightly for 6 weeks
Sleep quality
Sleep stage (%REM, %Deep sleep)
Nightly for 6 weeks
Dietary quality
3-day food recalls (ASA-24)
pre and post intervention (4-6 weeks)
Secondary Outcomes (5)
Generalized Anxiety Disorder (GAD-7)
pre and post intervention (4-6 weeks)
Patient Health Questionnaire-9
pre and post intervention (4-6 weeks)
Sport Anxiety Scale-2
pre and post intervention (4-6 weeks)
Pitching accuracy
pre and post intervention (4-6 weeks)
Isometric wall push
pre and post intervention (4-6 weeks)
Study Arms (1)
Sleep & diet intervention
EXPERIMENTALParticipants will be asked to increase their fruit and vegetable consumption, time in bed, and modify light exposure across the day
Interventions
Participants will be asked to increase their fruit and vegetable consumption, time in bed, and modify light exposure across the day
Eligibility Criteria
You may qualify if:
- Collegiate baseball player at Columbia University
You may not qualify if:
- None
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Idorsia Pharmaceuticals Ltd.collaborator
- Oura Ringcollaborator
- Columbia Universitylead
- University of Arizonacollaborator
Study Sites (1)
Columbia University Irving Medical Center
New York, New York, 10032, United States
MeSH Terms
Interventions
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Marie-Pierre St-Onge
Columbia University Vagelos College of Physicians & Surgeons
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NA
- Masking
- NONE
- Purpose
- PREVENTION
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Professor of Nutritional Medicine
Study Record Dates
First Submitted
September 23, 2025
First Posted
October 8, 2025
Study Start
September 16, 2025
Primary Completion
October 31, 2025
Study Completion
October 31, 2025
Last Updated
December 18, 2025
Record last verified: 2025-12